Citations Report
Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report
Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.
Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
105 | 141 | 28 | 8 | 28 |
Year wise citations received |
543 | 553 | 590 | 563 | 587 |
| Journal total citations count | 6601 |
| Journal Impact Factor | 6.49 |
| Journal 5 years Impact Factor | 12.17 |
| Journal CiteScore | 11.19 |
| Journal h-index | 41 |
| Journal h-index since 2016 | 26 |
Cox, David, Man K. Chan, and Sabine Bahn. "The potential of immune biomarkers to advance personalized medicine approaches for schizophrenia." The Journal of nervous and mental disease 203, no. 5 (2015): 393-399. |
|
Kim, Sung-Wan, Hee-Ju Kang, Min Jhon, Ju-Wan Kim, Ju-Yeon Lee, Adam J. Walker, Bruno Agustini, Jae-Min Kim, and Michael Berk. "Statins and inflammation: new therapeutic opportunities in psychiatry." Frontiers in psychiatry 10 (2019): 103. |
|
Ohnuma, Tohru, and Heii Arai. "Genetic or Psychogenic? A Case Study of “Folie à Quatre” Including Twins." Case reports in psychiatry 2015 (2015). |
|
Wouters, Elise, Lakshmi Vasudevan, René AJ Crans, Deepak K. Saini, and Christophe P. Stove. "Luminescence-and fluorescence-based complementation assays to screen for GPCR oligomerization: current state of the art." International journal of molecular sciences 20, no. 12 (2019): 2958. |
|
Xu, Jian, Pradeep Kurup, Angus C. Nairn, and Paul J. Lombroso. "Synaptic NMDA Receptor Activation Induces Ubiquitination and Degradation of STEP 61." Molecular neurobiology 55, no. 4 (2018): 3096-3111. |
|
Molinaro, Luke, Patricia Hui, Mattea Tan, and Ram K. Mishra. "Role of presynaptic phosphoprotein synapsin II in schizophrenia." World journal of psychiatry 5, no. 3 (2015): 260. |
|
Jafari, Somayeh, Marc E. Bouillon, Xu-Feng Huang, Stephen G. Pyne, and Francesca Fernandez-Enright. "Novel olanzapine analogues presenting a reduced H 1 receptor affinity and retained 5HT 2A/D 2 binding affinity ratio." BMC pharmacology 12, no. 1 (2012): 1-8. |
|
Lalley, Peter M., and Steve W. Mifflin. "Opposing effects on the phrenic motor pathway attributed to dopamine-D1 and-D3/D2 receptor activation." Respiratory physiology & neurobiology 181, no. 2 (2012): 183-193. |
|
Torrey, E. Fuller, Wendy W. Simmons, Elizabeth Sinclair Hancq, and John Snook. "The Continuing Decline of Clinical Research on Serious Mental Illnesses at NIMH." Psychiatric Services (2021): appi-ps. |
|
Shen, Hai-Ying, Nanxin Huang, Jesica Reemmer, and Lan Xiao. "Adenosine actions on oligodendroglia and myelination in autism spectrum disorder." Frontiers in cellular neuroscience 12 (2018): 482. |
|
GANDO, DR SATOSHI. "This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi." (2020). |
|
Norman, Andrew B., Michael R. Tabet, Mantana K. Norman, Brittney K. Fey, Vladimir L. Tsibulsky, and Ronald W. Millard. "The affinity of D2-like dopamine receptor antagonists determines the time to maximal effect on cocaine self-administration." Journal of Pharmacology and Experimental Therapeutics 338, no. 2 (2011): 724-728. |
|
Seeman, Philip. "Schizophrenia thalamus imaging: low benzamide binding to dopamine D2 receptors suggests fewer D2Short receptors and fewer presynaptic terminals." Psychiatry Research: Neuroimaging 214, no. 3 (2013): 175-180. |
|
Passos, Ives C., Pedro L. Ballester, Rodrigo C. Barros, Diego Librenza?Garcia, Benson Mwangi, Boris Birmaher, Elisa Brietzke et al. "Machine learning and big data analytics in bipolar disorder: a position paper from the International Society for Bipolar Disorders Big Data Task Force." Bipolar Disorders 21, no. 7 (2019): 582-594. |
|
Norman, Andrew B., Michael R. Tabet, Mantana K. Norman, and Vladimir L. Tsibulsky. "Using the self-administration of apomorphine and cocaine to measure the pharmacodynamic potencies and pharmacokinetics of competitive dopamine receptor antagonists." Journal of neuroscience methods 194, no. 2 (2011): 252-258. |
|
Lualdi, Marta, and Mauro Fasano. "Statistical analysis of proteomics data: a review on feature selection." Journal of proteomics 198 (2019): 18-26. |
|
Lee, Min-Jing, Pao-Yen Lin, Yung-Yee Chang, Mian-Yoon Chong, and Yu Lee. "Antipsychotics-induced tardive syndrome: a retrospective epidemiological study." Clinical neuropharmacology 37, no. 4 (2014): 111-115. |
|
Kukshal, Prachi, B. K. Thelma, Vishwajit L. Nimgaonkar, and Smita N. Deshpande. "Genetics of schizophrenia from a clinicial perspective." International review of psychiatry 24, no. 5 (2012): 393-404. |
|
Liu, Chunyu, Chuan Jiao, Kangli Wang, and Ning Yuan. "DNA methylation and psychiatric disorders." Progress in molecular biology and translational science 157 (2018): 175-232. |
|
Paruk, Saeeda, Khatija Jhazbhay, Keshika Singh, Benn Sartorius, and Jonathan K. Burns. "The clinical impact of a positive family history of psychosis or mental illness in psychotic and non-psychotic mentally ill adolescents." Journal of Child & Adolescent Mental Health 29, no. 3 (2017): 219-229. |
|